Dose: A critical factor in cancer chemotherapy
Emil Frei, George P. Canellos · The American Journal of Medicine · 1980
Cited by 839 works. doi:10.1016/0002-9343(80)90472-6
Authors
References
- The Effect of 6-Mercaptopurine on the Duration of Steroid-induced Remissions in Acute Leukemia: A Model for Evaluation of Other Potentially Useful Therapy
- Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts
- Studies of Sequential and Combination Antimetabolite Therapy in Acute Leukemia: 6-Mercaptopurine and Methotrexate
- Comparison of the Sensitivity of Normal Hematopoietic and Transplanted Lymphoma Colony-Forming Cells to Chemotherapeutic Agents Administered In Vivo 2
- Experimental evaluation of potential anticancer agents VIII. Effects of certain nitrosoureas on intracerebral L1210 leukemia.
- Drug dosage and remission duration in childhood lymphocytic leukemia
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP
- Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy
- Dose response evaluation of adriamycin in human neoplasia